DMCA
Results Conclusions
BibTeX
@MISC{Bethke_resultsconclusions,
author = {Lara Bethke and Anne Murray and Emily Webb and Minouk Schoemaker and Kenneth Muir and Patricia Mckinney and Sarah Hepworth and Polyxeni Dimitropoulou and Artitaya Lophatananon and Maria Feychting and Stefan Lönn and Christoffer Johansen and Helle Collatz Christensen and Michael Kosteljanetz and Anthony Swerdlow and Richard Houlston},
title = {Results Conclusions},
year = {}
}
Share
 |
 |
 |
 |
||
OpenURL
Abstract
Meningiomas account for up to 37 % of all primary brain tumors. Genetic susceptibility to meningioma is well established, with the risk among relatives of meningioma patients being approximately threefold higher than that in the general population. A relationship between risk of meningioma and exposure to ionizing radiation is also well known and led us to examine whether variants in DNA repair genes contribute to disease susceptibility. We analyzed 1127 tagging single-nucleotide polymorphisms (SNPs) that were selected to capture most of the common variation in 136 DNA repair genes in five case – control series (631 case patients and 637 control subjects) from four countries in Europe. We also analyzed 388 putative functional SNPs in these genes for their association with meningioma. All statistical tests were two-sided. The SNP rs4968451, which maps to intron 4 of the gene that encodes breast cancer susceptibility gene 1 – interacting protein 1, was consistently associated with an increased risk of developing meningioma. Across the five studies, the association was highly statistically significant (trend odds ratio = 1.57, 95% confidence interval = 1.28 to 1.93; P trend = 8.95 × 10 � 6; P =.009 after adjusting for multiple testing). We have identified a novel association between rs4968451 and meningioma risk. Because approximately 28 % of the European population are carriers of at-risk genotypes for rs4968451, the variant is likely to
